Industry guidance on the administration of tilmicosin.
D000818:Animals; D018942:Macrolides / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012449:Safety; D012952:Societies; D015645:Tylosin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006113:United Kingdom; D014730:Veterinary Medicine / Q000592:standards*
D018942:Macrolides; C052319:tilmicosin; D015645:Tylosin